Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are implicated in cancer development.
• Transforming growth factor beta receptor 2 (TGFβR2) signaling pathway dysregulation is common in various cancers, including gastric cancer (GC).
• The specific mechanisms controlling TGFβR2 expression in GC remain largely unelucidated.

Purpose of the Study:

• To investigate the role of miR-130 in regulating TGFβR2 expression in gastric cancer.
• To explore the functional consequences of miR-130 dysregulation on GC cell phenotypes.
• To determine if miR-130 acts as an oncogene in GC.

Main Methods:

• Analysis of TGFβR2 and miR-130 expression in GC tissues.
• Luciferase reporter assays to confirm direct binding of miR-130 to TGFβR2 3'UTR.
• In vitro experiments using miR-130 mimics and inhibitors in SGC7901 cells.
• siRNA-mediated knockdown of TGFβR2 to assess phenotypic changes.
• Correlation analysis between miR-130, TGFβR2, and epithelial-mesenchymal transition (EMT) markers.

Main Results:

• TGFβR2 protein was downregulated, while miR-130 expression was upregulated in GC tissues.
• miR-130 directly targets the 3'UTR of TGFβR2 mRNA.
• Overexpression of miR-130 decreased TGFβR2 levels and promoted SGC7901 cell proliferation and migration.
• Inhibition of miR-130 increased TGFβR2 expression.
• TGFβR2 knockdown mimicked the effects of miR-130 overexpression on cell phenotypes.
• A strong correlation was observed between miR-130 levels and EMT markers.

Conclusions:

• miR-130 directly targets and represses TGFβR2 in gastric cancer.
• miR-130 functions as an oncogene in GC by promoting proliferation and migration.
• The miR-130/TGFβR2 axis represents a significant regulatory mechanism in GC progression.